Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

PA153, a novel agent for the diagnosis and treatment of pancreatic diseases

Aug. 3, 1999

Structurally novel 5-HT3 receptor antagonist characterized in vitro and in vivo

July 30, 1999

Enzo Biochem begins human trial for HBV therapy

July 30, 1999

No adverse influence on cardiac repolarization seen in in vitro studies with tegaserod

July 29, 1999

Schering-Plough launches Rebetol combination therapy in the U.K.

July 28, 1999

Mechanism of gastroprotective effects of lafutidine determined in in vitro and in vivo studies

July 28, 1999

First i.v. proton pump inhibitor under review by FDA

July 23, 1999

Aminomethylchromanes with potential for dyspepsia disclosed by Janssen

July 22, 1999

American Home Products receives approvable letter for GERD therapy

July 21, 1999

HCV-specific antisense oligonucleotide undergoing advanced preclinical studies at Isis

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...